SwePub
Sök i LIBRIS databas

  Extended search

L773:2197 7364
 

Search: L773:2197 7364 > Radiation dosimetry...

Radiation dosimetry of [Ga-68]PSMA-11 in low-risk prostate cancer patients

Sandgren, Kristina (author)
Umeå University,Umeå universitet,Radiofysik
Johansson, Lennart (author)
Umeå University,Umeå universitet,Radiofysik
Axelsson, Jan, 1966- (author)
Umeå University,Umeå universitet,Radiofysik
show more...
Jonsson, Joakim, 1984- (author)
Umeå University,Umeå universitet,Radiofysik
Ögren, Mattias (author)
Umeå University,Umeå universitet,Diagnostisk radiologi
Ögren, Margareta (author)
Umeå University,Umeå universitet,Diagnostisk radiologi
Andersson, Martin (author)
Lund University,Lunds universitet,Medicinsk strålningsfysik, Malmö,Forskargrupper vid Lunds universitet,Medical Radiation Physics, Malmö,Lund University Research Groups
Strandberg, Sara (author)
Umeå University,Umeå universitet,Diagnostisk radiologi
Nyholm, Tufve (author)
Umeå University,Umeå universitet,Radiofysik
Riklund, Katrine (author)
Umeå University,Umeå universitet,Diagnostisk radiologi
Widmark, Anders (author)
Umeå University,Umeå universitet,Radiofysik
show less...
 (creator_code:org_t)
2019-01-11
2019
English.
In: EJNMMI Physics. - : Springer. - 2197-7364. ; 6
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Background: 68Ga-labeled Glu-NH-CO-NH-Lys(Ahx)-HBED-CC ([68Ga]PSMA-11) has been increasingly used to image prostate cancer using positron emission tomography (PET)/computed tomography (CT) both during diagnosis and treatment planning. It has been shown to be of clinical value for patients both in the primary and secondary stages of prostate cancer. The aim of this study was to determine the effective dose and organ doses from injection of [68Ga]PSMA-11 in a cohort of low-risk prostate cancer patients.Methods: Six low-risk prostate cancer patients were injected with 133–178 MBq [68Ga]PSMA-11 and examined with four PET/CT acquisitions from injection to 255 min post-injection. Urine was collected up to 4 h post-injection, and venous blood samples were drawn at 45 min, 85 min, 175 min, and 245 min post-injection. Kidneys, liver, lungs, spleen, salivary and lacrimal glands, and total body where delineated, and cumulated activities and absorbed organ doses calculated. The software IDAC-Dose 2.1 was used to calculate absorbed organ doses according to the International Commission on Radiological Protection (ICRP) publication 107 using specific absorbed fractions published in ICRP 133 and effective dose according to ICRP Publication 103. We also estimated the absorbed dose to the eye lenses using Monte Carlo methods.Results: [68Ga]PSMA-11 was rapidly cleared from the blood and accumulated preferentially in the kidneys and the liver. The substance has a biological half-life in blood of 6.5 min (91%) and 4.4 h (9%). The effective dose was calculated to 0.022 mSv/MBq. The kidneys received approximately 40 mGy after an injection with 160 MBq [68Ga]PSMA-11 while the lacrimal glands obtained an absorbed dose of 0.12 mGy per administered MBq. Regarding the eye lenses, the absorbed dose was low (0.0051 mGy/MBq).Conclusion: The effective dose for [68Ga]PSMA-11 is 0.022 mSv/MBq, where the kidneys and lacrimal glands receiving the highest organ dose.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Cancer and Oncology (hsv//eng)
MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Radiologi och bildbehandling (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Radiology, Nuclear Medicine and Medical Imaging (hsv//eng)

Keyword

Radiation dosimetry
[Ga-68]PSMA-11
PSMA
PET-tracer
Prostate cancer
Absorbed dose and effective dose
Glu-NH-CO-NH-Lys(Ahx)-HBED-CC
Absorbed dose and effective dose
Glu-NH-CO-NH-Lys(Ahx)-HBED-CC
PET-tracer
Prostate cancer
PSMA
Radiation dosimetry
[Ga]PSMA-11

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view